Forensic Analysis · Professional & Commercial Services · as of Aug 14, 2026
Angi Inc. (ANGI)
A forensic read on Angi Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Distress
Financial health
0.9
Distress distance
Clean
Earnings quality
4
Forensic signals
12.8
P / E (ttm)
4.7%
ROE
$252M
Market cap
-13.0%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Angi Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 0.9, placing it in the Distress zone. 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
4.0%
FY2025
Return on invested capital.Return on invested capital is 4.0% in the latest fiscal year and rising from -5% — well below its ~10% cost of capital, and it has been across FY2017–FY2025, so reinvested dollars have not been earning their keep.
327% of FCF
FY2025
Shareholder returns.Returned $149M to shareholders (buybacks + dividends) in FY2025 — 327% of free cash flow. More than free cash flow generated — and beyond operating cash too, so the extra is coming from debt or cash reserves, which isn't sustainable indefinitely. Counting the $15M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 359%.
n/m (stock split)
FY2022–FY2025
Share count (stock split).Diluted share count changed -91% over the last 3 years to FY2025, but that includes a large one-time change around FY2023 consistent with a stock split or reverse split, not gradual buybacks or issuance — a split changes the count with NO effect on any holder's proportional ownership, so the raw -54.8%/yr figure isn't a real buyback/dilution read here.
$55M
FY2019–FY2022
Goodwill impairments.Took $55M of goodwill writedowns across 2 years (FY2019 ($29M), FY2022 ($26M)). Writedowns mean past acquisitions underperformed what was paid for them.
Key fundamentals
Latest Revenue$1.03B
Revenue Growth YoY-13.0%
Revenue CAGR (3yr)-16.4%
Net Margin4.3%
Free Cash Flow$45.5M
Return on Equity4.7%
Debt / Equity0.54x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Angi Inc.'s actual 10-K/10-Q/8-K filings?